Parametric Portfolio Associates’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$26K	Sell	36,219 -23,045	-39%	-$49.3K	﹤0.01%	3655
2021 Q4	$134K	Sell	59,264 -30,193	-34%	-$82.3K	﹤0.01%	3507
2021 Q3	$258K	Sell	89,457 -37,012	-29%	-$106K	﹤0.01%	3356
2021 Q2	$479K	Sell	126,469 -68,028	-35%	-$229K	﹤0.01%	3103
2021 Q1	$658K	Sell	194,497 -64,643	-25%	-$233K	﹤0.01%	3358
2020 Q4	$726K	Buy	259,140 +199,283	+333%	+$582K	﹤0.01%	3202
2020 Q3	$150K	Sell	59,857 -124,180	-67%	-$1.09M	﹤0.01%	3727
2020 Q2	$2.5M	Buy	184,037 +83,340	+83%	+$862K	﹤0.01%	2364
2020 Q1	$763K	Buy	100,697 +32,414	+47%	+$252K	﹤0.01%	2950
2019 Q4	$432K	Sell	68,283 -145,437	-68%	-$691K	﹤0.01%	3422
2019 Q3	$838K	Buy	213,720 +14,204	+7%	+$60.9K	﹤0.01%	3111
2019 Q2	$966K	Buy	199,516 +64,835	+48%	+$369K	﹤0.01%	3065
2019 Q1	$1.1M	Sell	134,681 -114,788	-46%	-$788K	﹤0.01%	2981
2018 Q4	$1.38M	Buy	249,469 +227,364	+1,029%	+$1.78M	﹤0.01%	2812
2018 Q3	$195K	Sell	22,105 -885	-4%	-$7.92K	﹤0.01%	3769
2018 Q2	$229K	Buy	22,990 +5,626	+32%	+$56.3K	﹤0.01%	3655
2018 Q1	$165K	Sell	17,364 -78,100	-82%	-$1.09M	﹤0.01%	3797
2017 Q4	$1.42M	Sell	95,464 -9,734	-9%	-$161K	﹤0.01%	2823
2017 Q3	$2.07M	Buy	105,198 +31,074	+42%	+$478K	﹤0.01%	2565
2017 Q2	$1.06M	Buy	+74,124	New	+$940K	﹤0.01%	2951
2016 Q4	–	Sell	-10,555	Closed	-$96K	–	3769
2016 Q3	$96K	Buy	+10,555	New	+$89.7K	﹤0.01%	3687
2016 Q1	–	Sell	-23,807	Closed	-$308K	–	3968
2015 Q4	$308K	Buy	23,807 +12,731	+115%	+$130K	﹤0.01%	3551
2015 Q3	$107K	Sell	11,076 -666	-6%	-$6.11K	﹤0.01%	3182
2015 Q2	$121K	Buy	+11,742	New	+$100K	﹤0.01%	3850